Two Years of Denosumab and Teriparatide Administration in Postmenopausal Women With Osteoporosis (The DATA Extension Study): A Randomized Controlled Trial

CONTEXT: Current osteoporosis medications increase bone mineral density (BMD) modestly and reduce, but do not eliminate, fracture risk. Attempts to improve efficacy by administering anabolic agents and bisphosphonates concomitantly have been unsuccessful. Conversely, 12 months of concomitant denosum...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Leder, Benjamin Z., Tsai, Joy N., Uihlein, Alexander V., Burnett-Bowie, Sherri-Ann M., Zhu, Yuli, Foley, Katelyn, Lee, Hang, Neer, Robert M.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2013
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4083737/
https://ncbi.nlm.nih.gov/pubmed/23683600
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S0140-6736(13)60856-9
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak